Circulating levels of osteopontin were found to be higher in melanoma patients as compared with healthy subjects [31–33], higher in patients with metastatic disease as compared with non-metastatic patients, and positively associated with Breslow thickness [29, 30]. Here, SPP1 is linked to melanoma.